Meaghan Boileau

526 total citations
8 papers, 107 citations indexed

About

Meaghan Boileau is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Meaghan Boileau has authored 8 papers receiving a total of 107 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Hematology and 2 papers in Genetics. Recurrent topics in Meaghan Boileau's work include Acute Myeloid Leukemia Research (4 papers), Protein Degradation and Inhibitors (4 papers) and Histone Deacetylase Inhibitors Research (3 papers). Meaghan Boileau is often cited by papers focused on Acute Myeloid Leukemia Research (4 papers), Protein Degradation and Inhibitors (4 papers) and Histone Deacetylase Inhibitors Research (3 papers). Meaghan Boileau collaborates with scholars based in Canada, United States and Germany. Meaghan Boileau's co-authors include Kolja Eppert, Isabelle Laverdière, Stanley Ng, Mark D. Minden, Jean Wang, Taylor P. A. Hari, Christopher N. Boddy, Andrea Neumann, Amanda Mitchell and Janusz Rak and has published in prestigious journals such as Blood, EMBO Reports and ChemBioChem.

In The Last Decade

Meaghan Boileau

7 papers receiving 106 citations

Peers

Meaghan Boileau

MB

HEMAT

PHARM

IMMUN

OC

Yuko Nishiyama Japan

Joseph A. Pope United States

Annika Jenmalm Jensen Sweden

Natalie Roy D’Amore United States

Xuegeng Shi China

Aman Seth United States

John Sapienza Switzerland

Jin Zeng China

Janice Schindler‐Horvat United States

Sébastien P. Dion Canada

Yuko Nishiyama Japan

Meaghan Boileau

89 ×1.3

MB

7 ×0.2

HEMAT

10 ×0.4

PHARM

11 ×0.6

IMMUN

49 ×3.5

OC

Citations per year, relative to Meaghan Boileau Meaghan Boileau (= 1×) peers Yuko Nishiyama

Countries citing papers authored by Meaghan Boileau

Since Specialization

Citations

This map shows the geographic impact of Meaghan Boileau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meaghan Boileau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meaghan Boileau more than expected).

Fields of papers citing papers by Meaghan Boileau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meaghan Boileau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meaghan Boileau. The network helps show where Meaghan Boileau may publish in the future.

Co-authorship network of co-authors of Meaghan Boileau

This figure shows the co-authorship network connecting the top 25 collaborators of Meaghan Boileau. A scholar is included among the top collaborators of Meaghan Boileau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meaghan Boileau. Meaghan Boileau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Loke, Justin, Peter G. Kim, Thuy T. P. Nguyen, et al.. (2025). An in vivo barcoded CRISPR-Cas9 screen identifies Ncoa4-mediated ferritinophagy as a dependence in Tet2-deficient hematopoiesis. Blood. 146(10). 1174–1186. 2 indexed citations

2.

Godfrey, Laura, Charlie Hatton, Daniela V. Wenge, et al.. (2025). p300/CBP is an essential driver of pathogenic enhancer activity and gene expression in Ewing sarcoma. EMBO Reports. 26(19). 4766–4793. 1 indexed citations

3.

Kim, Geon, Meaghan Boileau, Thuy T. P. Nguyen, et al.. (2024). In Vivo barcoded CRISPR-Cas9 Screen Identifies Ncoa4-mediated Ferritinophagy As a Dependence in Tet2-Deficient Haemopoiesis. Blood. 144(Supplement 1). 188–188.

4.

Laverdière, Isabelle, Meaghan Boileau, Andrea Neumann, et al.. (2018). Leukemic stem cell signatures identify novel therapeutics targeting acute myeloid leukemia. Blood Cancer Journal. 8(6). 52–52. 60 indexed citations

5.

Boileau, Meaghan, Isabelle Laverdière, Amanda Mitchell, et al.. (2016). Identification of existing bioactive molecules that target acute myeloid leukemia stem cells. Experimental Hematology. 44(9). S60–S61. 1 indexed citations

6.

Laverdière, Isabelle, Meaghan Boileau, Tobias Herold, et al.. (2016). Complement cascade gene expression defines novel prognostic subgroups of acute myeloid leukemia. Experimental Hematology. 44(11). 1039–1043.e10. 15 indexed citations

7.

Laverdière, Isabelle, Andrea Neumann, Meaghan Boileau, et al.. (2015). Identification of Existing Bioactive Compounds That Target Acute Myeloid Leukemia Stem Cells. Blood. 126(23). 3681–3681. 1 indexed citations

8.

Hari, Taylor P. A., et al.. (2014). An Evolutionary Model Encompassing Substrate Specificity and Reactivity of Type I Polyketide Synthase Thioesterases. ChemBioChem. 15(18). 2656–2661. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact